Walgreens Boots Alliance (WBA)
(Delayed Data from NSDQ)
$8.91 USD
-0.17 (-1.87%)
Updated Oct 9, 2024 04:00 PM ET
After-Market: $8.91 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
C Value D Growth F Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$8.91 USD
-0.17 (-1.87%)
Updated Oct 9, 2024 04:00 PM ET
After-Market: $8.91 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
C Value D Growth F Momentum D VGM
Zacks News
Company News for Jan 8, 2021
by Zacks Equity Research
Companies in The News Are: BBBY,WBA,STZ,SCHN
Walgreens Boots (WBA) Q1 Earnings Top Estimates, Margins Down
by Zacks Equity Research
Walgreens Boots' (WBA) fiscal first-quarter results reflect overall top-line improvement despite COVID-19-led business disruptions.
AmerisourceBergen (ABC), WBA Ink Deal to Focus on Core Arms
by Zacks Equity Research
AmerisourceBergen (ABC) and Walgreens (WBA) enter into a key strategic deal to boost focus on core businesses, while extending their partnership.
Company News for Jan 7, 2021
by Zacks Equity Research
Companies in The News Are: CGNG,UNH,MRNA,WBA,ABC,GTH
Walgreens Boots Alliance (WBA) Q1 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Walgreens (WBA) delivered earnings and revenue surprises of 19.61% and 3.95%, respectively, for the quarter ended November 2020. Do the numbers hold clues to what lies ahead for the stock?
Will Walgreens Boots' (WBA) Retail Arm Be Dull in Q1 Earnings?
by Zacks Equity Research
Walgreens Boots' (WBA) retail pharmacy international sales are likely to remain dull in Q1 on difficult market scenario in the United Kingdom.
Earnings Preview: Walgreens Boots Alliance (WBA) Q1 Earnings Expected to Decline
by Zacks Equity Research
Walgreens (WBA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Stock Market News for Dec 23, 2020
by Zacks Equity Research
Benchmarks closed mixed on Tuesday as investors remained concerned about rising coronavirus cases in America and Europe despite a vaccine rollout in progress and additional stimulus package.
Stock Market News for Dec 17, 2020
by Zacks Equity Research
U.S. stock markets closed mixed on Wednesday as investors were weighing the prospect of a new fiscal stimulus this year.
Verizon (VZ) to Transform Walgreens Boots Alliance's Network
by Zacks Equity Research
Verizon (VZ) customizes an offering that is likely to meet Walgreens' technology needs and also serve as a foundation for the deployment of 5G.
Walgreens Boots Alliance (WBA) Stock Moves -0.12%: What You Should Know
by Zacks Equity Research
Walgreens Boots Alliance (WBA) closed at $41.48 in the latest trading session, marking a -0.12% move from the prior day.
Walgreens Boots Alliance (WBA) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Walgreens Boots Alliance (WBA) closed at $41.99 in the latest trading session, marking a -1.04% move from the prior day.
Stock Market News for Dec 4, 2020
by Zacks Equity Research
U.S. stock markets closed modestly higher on Thursday after falling from record intraday highs.
Walgreens Boots Alliance (WBA) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Walgreens Boots Alliance (WBA) closed at $38.46, marking a +1.18% move from the previous day.
Walgreens Boots Alliance (WBA) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Walgreens Boots Alliance (WBA) closed at $39.07 in the latest trading session, marking a +1.43% move from the prior day.
Walgreens Boots Alliance (WBA) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Walgreens Boots Alliance (WBA) closed at $37.85, marking a -0.99% move from the previous day.
Amazon (AMZN) Ups Pharmacy Retail Game With New Online Store
by Zacks Equity Research
Amazon (AMZN) unveils Amazon Pharmacy, the new online store for prescription medicines. This is likely to drive its customer momentum amid the pandemic.
Stock Market News for Nov 18, 2020
by Zacks Equity Research
U.S. stock markets closed lower on Tuesday on concerns of coronavirus resurgence.
Markets Roll Back from All-Time Highs: WBA, WMT, KBH & More
by Mark Vickery
This is the first down close in the last three sessions for the main indexes, which were once again outpaced by the small-cap Russell 2000.
Dow ETF Hits New Highs on Vaccine Optimism: 5 Best Stocks
by Sweta Killa
The Dow Jones hit all-time highs since February, marking its fastest bear market recovery in 30 years.
Walgreens (WBA) Up 13.5% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Walgreens (WBA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Microsoft (MSFT) Q1 Earnings Top, Azure Drives Top Line
by Zacks Equity Research
Microsoft's (MSFT) fiscal first-quarter results benefit from momentum in Azure, impressive Teams user growth led by work-from-home wave and uptake of Surface devices and Xbox Game Pass.
Zacks Industry Outlook Highlights: CVS, Walgreens Boots, Rite Aid, Amazon and Herbalife
by Zacks Equity Research
Zacks Industry Outlook Highlights: CVS, Walgreens Boots, Rite Aid, Amazon and Herbalife
2 Top Retail Pharmacy and Drug Store Stocks to Beat Volatility
by Urmimala Biswas
Social-distancing measures to combat coronavirus have dented demand for Retail Pharmacy and Drug Store industry, casting a shadow on its outlook. Industry participants like CVS and HLF however seem to be in a position to tide over the situation.
Company News for Oct 16, 2020
by Zacks Equity Research
Companies In The News Are: SCHW, MS, WBA, TSM.